These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 25832428)
1. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428 [TBL] [Abstract][Full Text] [Related]
2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
3. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
4. Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells. Chen YH; Lan T; Li J; Qiu CH; Wu T; Gou HJ; Lu MQ World J Gastroenterol; 2012 Dec; 18(48):7158-65. PubMed ID: 23326120 [TBL] [Abstract][Full Text] [Related]
5. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. Xu L; Zheng N; He Q; Li R; Zhang K; Liang T Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441 [TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress. Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation. Shen K; Feng X; Su R; Xie H; Zhou L; Zheng S PLoS One; 2015; 10(5):e0126278. PubMed ID: 25955525 [TBL] [Abstract][Full Text] [Related]
8. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783 [TBL] [Abstract][Full Text] [Related]
9. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Ge M; Liu H; Zhang Y; Li N; Zhao S; Zhao W; Zhen Y; Yu J; He H; Shao RG Br J Pharmacol; 2017 May; 174(10):1147-1160. PubMed ID: 28257144 [TBL] [Abstract][Full Text] [Related]
10. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Kobayashi H; Tanaka Y; Asagiri K; Asakawa T; Tanikawa K; Kage M; Yagi M Phytomedicine; 2010 Mar; 17(3-4):197-202. PubMed ID: 20092986 [TBL] [Abstract][Full Text] [Related]
11. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats. Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324 [TBL] [Abstract][Full Text] [Related]
12. Experimental study on H Bai Y; Liu F; Luo S; Wan Y; Zhang L; Wu X; Chen Q; Xie Y; Guo P J Ethnopharmacol; 2024 Dec; 335():118712. PubMed ID: 39173724 [TBL] [Abstract][Full Text] [Related]
13. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498 [TBL] [Abstract][Full Text] [Related]
15. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. Wu L; Zhang Q; Mo W; Feng J; Li S; Li J; Liu T; Xu S; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C Sci Rep; 2017 Aug; 7(1):9289. PubMed ID: 28839277 [TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation. Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665 [TBL] [Abstract][Full Text] [Related]
17. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275 [TBL] [Abstract][Full Text] [Related]
18. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro. Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587 [TBL] [Abstract][Full Text] [Related]
20. [Hydroxynitone suppresses hepatic stellate cell activation by inhibiting TGF-β1 phosphorylation to alleviate CCl Zhao Z; Dong H; Li B; Shen B; Guo Y; Gu T; Qu Y; Cai X; Lu L Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1511-1516. PubMed ID: 36329585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]